Why the study?
Although the LIMA-RA-Y technique achieves total arterial revascularization, LIMA with supplementary saphenous vein grafts remains the most common coronary reconstruction, prompting a long-term survival comparison between the two approaches.
Population
346 LIMA-RA-Y, 534 LIMA + SVG, and 5,800 other TAR patients from Royal Melbourne Hospital
Comparison
LIMA-RA-Y graft vs conventional LIMA + SVG and vs other TAR configurations
Design
Single-institution propensity score-matched survival comparison
Follow-up
21-year survival assessed at June 2017
Answers are grounded in this paper and cite their sources.
Demonstrates superior 21-year survival with arterial Y-grafts compared to saphenous vein grafts in coronary bypass patients, indicating long-term advantages of total arterial revascularization.
BACKGROUND In 1999, Royse et al. reported on the left internal mammary artery, radial artery, Y-graft technique (LIMA-RA-Y), which achieves total arterial revascularization (TAR). However, the most common coronary reconstruction remains LIMA and supplementary saphenous vein grafts (LIMA + SVG). OBJECTIVES The goal of this study was to conduct a survival comparison of LIMA-RA-Y versus the conventional LIMA + SVG. METHODS Of the original 464 LIMA-RA-Y patients reported (1996 to 1998), 346 were from the Royal Melbourne Hospital. Survival at June 2017 was compared with a group of 534 patients from 1996 to 2003 from the same institution who received LIMA + SVG, or 5,800 patients who received TAR with different grafting configurations. Propensity score matching (PSM) was performed with 1:1 matching using 26 variables. Comparisons used Kaplan-Meier (KM) and Cox proportional hazards methods. LIMA-RA-Y was compared with LIMA + SVG in which all non-left anterior descending artery grafts were performed with either composite RA or aorta-coronary SVG with no use of right internal mammary artery. We also conducted a comparison of LIMA-RA-Y versus TAR. RESULTS Baseline characteristics of the LIMA-RA-Y group (n = 346) compared with LIMA + SVG (n = 534) after PSM (n = 232 pairs) did not differ (3.3 ± 0.8 grafts per patient). Survival was worse for LIMA + SVG in the unmatched groups (KM, p < 0.001) and for PSM groups (KM, p = 0.043; Cox proportional hazards ratio: 1.3; 95% confidence interval: 1.0 to 1.6; p = 0.038). Survival did not differ between LIMA-RA-Y and other TAR (n = 5,800) patients before, or after, PSM (n = 332 pairs). CONCLUSIONS Use of LIMA + SVG has worse survival than LIMA-RA-Y in achieving total arterial revascularization.
No takes yet. Share an insight, caveat, or question.
Royse et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: